News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
126 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17656)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Deals
Alzheon Launches Roadshow for Initial Public Offering
Alzheon is offering 5,000,000 shares of its common stock at an initial public offering price between $13.00 and $15.00 per share.
April 2, 2018
·
2 min read
Biotech Beach
Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date
The four-part supplement, which includes the Company’s finalized 10-year FDA Core Study, provides a comprehensive look at the long-term outcomes, surgical best practices and product differentiation of Sientra’s breast implants and tissue expanders.
April 2, 2018
·
3 min read
Business
Biostage Reports 2017 Financial Results
Fourth Quarter Headcount Reduction and Private Placement Extend Operational Runway.
April 2, 2018
·
21 min read
FDA
Cardiome Highlights Partner SteadyMed’s Progress Towards Trevyent NDA Resubmission
Trevyent® is for the treatment of pulmonary arterial hypertension
April 2, 2018
·
6 min read
Business
Slayback Pharma Appoints Abhijit Mukherjee as Senior Advisor
Abhijit will advise the company on strategic and operational matters.
April 2, 2018
·
1 min read
Biotech Bay
Twist Bioscience Completes $50 Million Financing to Fuel Advancement of Digital Storage in DNA and Drug Discovery
Completion of a private placement of $50 million, brings the total raised to $259 million since the company’s founding in 2013.
April 2, 2018
·
2 min read
Business
ResMed Hires Bobby Ghoshal as First Chief Technology Officer
Ghoshal has more than 25 years’ experience in information technology, semiconductor innovation, digital strategy, information security, advanced analytics, operations and customer care
April 2, 2018
·
2 min read
Business
PharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation
The cells from the MCB will be encapsulated and then tested by Austrianova after encapsulation
April 2, 2018
·
4 min read
Lone Star Bio
AngioSoma, Inc. (OTC: SOAN) Announces Launch of www.soma-ceuticals.com Website
We are pleased to announce we have initiated our new website, http://www.soma-ceuticals.com to market our SomaceuticalsTM line of health supplements.
April 2, 2018
·
2 min read
Pharm Country
Cycle for Survival Raises A Record-Breaking $39 Million In 2018 For Rare Cancer Research
With support from founding partner Equinox, Cycle for Survival reaches a fundraising milestone; every dollar goes to rare cancer research led by Memorial Sloan Kettering Cancer Center
April 2, 2018
·
5 min read
Previous
7 of 13
Next